Literature DB >> 26495781

Low Stromal Area and High Stromal Microvessel Density Predict Poor Prognosis in Pancreatic Cancer.

Takahiro Nishida1, Hideyuki Yoshitomi, Shigetsugu Takano, Shingo Kagawa, Hiroaki Shimizu, Masayuki Ohtsuka, Atsushi Kato, Katsunori Furukawa, Masaru Miyazaki.   

Abstract

OBJECTIVES: Excessive stroma is a unique property of cancer tissue of the pancreas. The aim of this study was to analyze the relationship of cancer stromal area (SA) and tumor microvessel density (MVD) with prognostic and clinicopathological findings.
METHODS: Pancreatic adenocarcinoma tissues obtained from 104 patients were subjected to cytokeratin 19 and CD31 double immunostaining to identify cancer cells and endothelial cells simultaneously. Stromal area and MVD were assessed in the same sections. Patients were divided into 2 groups for each analysis by the median value of the respective measure.
RESULTS: Stromal area negatively correlated with MVD. The low SA group harbored more poorly differentiated carcinoma than the high SA group. Patients of the low SA group showed a higher incidence of hematogenous recurrence. As a consequence, patients in the low SA and the high MVD groups had poorer prognosis in terms of both disease-free survival and overall survival than their respective groups. Multivariate analysis showed that a low SA was an independent prognostic factor for disease-free and overall survival.
CONCLUSIONS: Our data indicate that the stroma of pancreatic cancer may play an auxiliary role as a barrier to cancer cell invasion. The depletion of tumor stroma alone does not suppress pancreatic cancer progression.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26495781     DOI: 10.1097/MPA.0000000000000499

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  5 in total

1.  Development of a multicellular pancreatic tumor microenvironment system using patient-derived tumor cells.

Authors:  Daniel Gioeli; Chelsi J Snow; Michael B Simmers; Stephen A Hoang; Robert A Figler; J Ashe Allende; Devin G Roller; J Thomas Parsons; Julia D Wulfkuhle; Emanuel F Petricoin; Todd W Bauer; Brian R Wamhoff
Journal:  Lab Chip       Date:  2019-03-27       Impact factor: 6.799

2.  VEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival.

Authors:  Eric Morin; Elin Sjöberg; Vegard Tjomsland; Chiara Testini; Cecilia Lindskog; Oskar Franklin; Malin Sund; Daniel Öhlund; Sara Kiflemariam; Tobias Sjöblom; Lena Claesson-Welsh
Journal:  J Pathol       Date:  2018-09-04       Impact factor: 7.996

3.  Reduction of intrapancreatic neural density in cancer tissue predicts poorer outcome in pancreatic ductal carcinoma.

Authors:  Toshimitsu Iwasaki; Nobuyoshi Hiraoka; Yoshinori Ino; Kosei Nakajima; Yoji Kishi; Satoshi Nara; Minoru Esaki; Kazuaki Shimada; Hitoshi Katai
Journal:  Cancer Sci       Date:  2019-03-19       Impact factor: 6.716

Review 4.  Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy.

Authors:  Ming Jia; Dan Zhang; Chunxiang Zhang; Chunhong Li
Journal:  J Nanobiotechnology       Date:  2021-11-22       Impact factor: 10.435

Review 5.  Pancreatic cancer stroma: an update on therapeutic targeting strategies.

Authors:  Abdel N Hosein; Rolf A Brekken; Anirban Maitra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-11       Impact factor: 73.082

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.